Journal
FEBS JOURNAL
Volume 290, Issue 9, Pages 2246-2262Publisher
WILEY
DOI: 10.1111/febs.16429
Keywords
bioactive peptides; cancer; dipeptidyl peptidase 3 (DPP3); Keap1-Nrf2 pathway; metalloprotease; oxidative stress; renin angiotensin system (RAS)
Categories
Ask authors/readers for more resources
This review focuses on recent advances in understanding the structure, catalytic activity, and physiological relevance of Dipeptidyl peptidase 3 (DPP3). The article highlights the broader role of DPP3 as a valuable biomarker in cardiovascular and renal pathologies, as well as its potential as a promising drug target.
Dipeptidyl peptidase 3 (DPP3), a zinc-dependent aminopeptidase, is a highly conserved enzyme among higher animals. The enzyme cleaves dipeptides from the N-terminus of tetra- to decapeptides, thereby taking part in activation as well as degradation of signalling peptides critical in physiological and pathological processes such as blood pressure regulation, nociception, inflammation and cancer. Besides its catalytic activity, DPP3 moonlights as a regulator of the cellular oxidative stress response pathway, e.g., the Keap1-Nrf2 mediated antioxidative response. The enzyme is also recognized as a key modulator of the renin-angiotensin system. Recently, DPP3 has been attracting growing attention within the scientific community, which has significantly augmented our knowledge of its physiological relevance. Herein, we review recent advances in our understanding of the structure and catalytic activity of DPP3, with a focus on attributing its molecular architecture and catalytic mechanism to its wide-ranging biological functions. We further highlight recent intriguing reports that implicate a broader role for DPP3 as a valuable biomarker in cardiovascular and renal pathologies and furthermore discuss its potential as a promising drug target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available